Injectable Therapies After Prostate Cancer Therapy
Author:
McCullough Andrew
Reference36 articles.
1. Stanford, J.L., Feng, Z., Hamilton, A.S., et al. (2000) Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA
283
(3), 354–360. 2. Litwin, M.S., Flanders, S.C., Pasta, D.J., Stoddard, M.L., Lubeck, D.P., and Henning, J.M. (1999) Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology
54(3), 503–508. 3. Lilleby, W., Fossa, S.D., Waehre, H.R., and Olsen, D.R. (1999) Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int. J. Radiat. Oncol. Biol. Phys. 43(4), 735–743. 4. Penson, D.F., Feng, Z., Kuniyuki, A., et al. (2003) General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J. Clin. Oncol. 21(6), 1147–1154. 5. Stephenson, R.A., Mori, M., and Hsieh, Y.C., et al. (2005) Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study. J. Urol. 174(2), 646–650; discussion 50.
|
|